References
- Joó F. Endothelial cells of the brain and other organ systems: some similarities and differences. Prog Neurobiol. 1996;48(3):1–23. doi:https://doi.org/10.1016/0301-0082(95)00046-1.
- Abbott NJ. Blood-brain barrier structure and function and the challenges for CNS drug delivery. J Inherit Metab Dis. 2013;36(3):437–449. doi:https://doi.org/10.1007/s10545-013-9608-0.
- Turksen K, Troy TC. Barriers built on claudins. J Cell Sci. 2004; 117 (Pt 12): 2435–2447. doi:https://doi.org/10.1242/jcs.01235.
- Deli MA. Potential use of tight junction modulators to reversibly open membranous barriers and improve drug delivery. Biochim Biophys Acta. 2009;1788(4):892–910. doi:https://doi.org/10.1016/j.bbamem.2008.09.016.
- Kaya M, Ahishali B. Basic physiology of the blood-brain barrier in health and disease: a brief overview. Tissue Barriers. 2021;9(1):1840913. doi:https://doi.org/10.1080/21688370.2020.1840913
- Campos-Bedolla P, Walter FR, Veszelka S, Deli MA. Role of the blood-brain barrier in the nutrition of the central nervous system. Arch Med Res. 2014;45(8):610–638. doi:https://doi.org/10.1016/j.arcmed.2014.11.018.
- Nagy Z, Peters H, Hüttner I. Endothelial surface charge: blood-brain barrier opening to horseradish peroxidase induced by the polycation protamin sulfate. Acta Neuropathol Suppl. 1981;7:7–9. doi:https://doi.org/10.1007/978-3-642-81553-9_2.
- Nagy Z, Peters H, Hüttner I. Charge-related alterations of the cerebral endothelium. Lab Invest. 1983;49:662–671.
- Nagy Z, Szabó M, Hüttner I. Blood-brain barrier impairment by low pH buffer perfusion via the internal carotid artery in rat. Acta Neuropathol. 1985;68(2):160–163. doi:https://doi.org/10.1007/BF00688639.
- Joó F, Karnushina I. A procedure for the isolation of capillaries from rat brain. Cytobios. 1973;8:41–48.
- Joó F. The blood-brain barrier in vitro: the second decade. Neurochem Int. 1993;23(6):499–521. doi:https://doi.org/10.1016/0197-0186(93)90098-p.
- Bénistant C, Dehouck MP, Fruchart JC, Cecchelli R, Lagarde M. Fatty acid composition of brain capillary endothelial cells: effect of the coculture with astrocytes. J Lipid Res. 1995;36(11):2311–2319. doi:https://doi.org/10.1016/S0022-2275(20)39712-1.
- Betsholtz C. Physiology: Double function at the blood-brain barrier. Nature. 2014;509(7501):432–433. doi:https://doi.org/10.1038/nature13339
- Tewes BJ, Galla HJ. Lipid polarity in brain capillary endothelial cells. Endothelium. 2001;8(3):207–220. doi:https://doi.org/10.1080/10623320109051566.
- Campbell SD, Regina KJ, Kharasch ED, Campbell SD, Regina KJ, Kharasch ED. Significance of lipid composition in a blood-brain barrier-mimetic PAMPA assay. J Biomol Screen. 2014;19(3):437–444. doi:https://doi.org/10.1177/1087057113497981.
- Ribeiro MMB, Domingues MM, Freire JM, Santos NC, Castanho MARB. Translocating the blood-brain barrier using electrostatics. Front Cell Neurosci. 2012;6:44. doi:https://doi.org/10.3389/fncel.2012.00044.
- Reed MJ, Damodarasamy M, Banks WA. The extracellular matrix of the blood-brain barrier: structural and functional roles in health, aging, and Alzheimer’s disease. Tissue Barriers. 2019;7(4):1651157. doi:https://doi.org/10.1080/21688370.2019.1651157.
- Fu BM, Tarbell JM. Mechano-sensing and transduction by endothelial surface glycocalyx: composition, structure, and function. Wiley Interdiscip Rev Syst Biol Med. 2013;5(3):381–390. doi:https://doi.org/10.1002/wsbm.1211.
- Zeng Y, Zhang XF, Fu BM, Tarbell JM. The role of endothelial surface glycocalyx in mechanosensing and transduction. Adv Exp Med Biol. 2018;1097:1–27. doi:https://doi.org/10.1007/978-3-319-96445-4_1.
- Reitsma S, Slaaf DW, Vink H, van Zandvoort MA, oude Egbrink MG. The endothelial glycocalyx: composition, functions, and visualization. Pflugers Arch. 2007;454(3):345–359. doi:https://doi.org/10.1007/s00424-007-0212-8
- Fan J, Sun Y, Xia Y, Tarbell JM, Fu BM, Tarbell J, Vink H. Endothelial surface glycocalyx (ESG) components and ultra-structure revealed by stochastic optical reconstruction microscopy (STORM). Biorheology. 2019;56(2–3):77–88. doi:https://doi.org/10.3233/BIR-180204.
- Vorbrodt AW. Ultracytochemical characterization of anionic sites in the wall of brain capillaries. J Neurocytol. 1989;18(3):359–368. doi:https://doi.org/10.1007/BF01190839.
- Ando Y, Okada H, Takemura G, Suzuki K, Takada C, Tomita H, Zaikokuji R, Hotta Y, Miyazaki N, Yano H, et al. Brain-specific ultrastructure of capillary endothelial glycocalyx and its possible contribution for blood brain barrier. Sci Rep. 2018;8(1):17523. doi:https://doi.org/10.1038/s41598-018-35976-2.
- Kutuzov N, Flyvbjerg H, Lauritzen M. Contributions of the glycocalyx, endothelium, and extravascular compartment to the blood-brain barrier. Proc Natl Acad Sci U S A. 2018;115(40):E9429–E9438. doi:https://doi.org/10.1073/pnas.1802155115.
- Li G, Yuan W, Fu BM. A model for the blood-brain barrier permeability to water and small solutes. J Biomech. 2010;43(11):2133–2140. doi:https://doi.org/10.1016/j.jbiomech.2010.03.047.
- Deli MA, Ábrahám CS, Kataoka Y, Niwa M. Permeability studies on in vitro blood-brain barrier models: physiology, pathology, and pharmacology. Cell Mol Neurobiol. 2005;25(1):59–127. doi:https://doi.org/10.1007/s10571-004-1377-8.
- Deli MA. Drug transport and the blood-brain barrier: chapter 8. Tihanyi K, Vastag M. editors. Solubility, delivery, and ADME problems of drugs and drug-candidates. ISBN: 978-1-60805-619-4. Bentham Science Publishers Ltd; 2011. 144–165. doi:https://doi.org/10.2174/978160805120511101010144
- Banks WA. From blood-brain barrier to blood-brain interface: new opportunities for CNS drug delivery. Nat Rev Drug Discov. 2016;15(4):275–292. doi:https://doi.org/10.1038/nrd.2015.21.
- Sahagun G, Moore SA, Hart MN. Permeability of neutral vs. anionic dextrans in cultured brain microvascular endothelium. Am J Physiol. 1990;259(1Pt2):H162-H166. doi:https://doi.org/10.1152/ajpheart.1990.259.1.H162
- Leveugle B, Ding W, Laurence F, Dehouck M-P, Scanameo A, Cecchelli R, Fillit H. Heparin oligosaccharides that pass the blood-brain barrier inhibit β-amyloid precursor protein secretion and heparin binding to β-amyloid peptide. J Neurochem. 1998;70(2):736–744. doi:https://doi.org/10.1046/j.1471-4159.1998.70020736.x.
- Smith KR, Borchardt RT. Permeability and mechanism of albumin, cationized albumin, and glycosylated albumin transcellular transport across monolayers of cultured bovine brain capillary endothelial cells. Pharm Res. 1989;6(6):466–473. doi:https://doi.org/10.1023/a:1015960205409.
- Girod J, Fénart L, Régina A, Dehouck M-P, Hong G, Schermann J-M, Cecchelli R, Roux F. Transport of cationized anti-tetanus Fab’2 fragments across an in vitro blood-brain barrier model: involvement of the transcytosis pathway. J Neurochem. 1999;73(5):2002–2008. doi:https://doi.org/10.1046/j.1471-4159.1999.02002.x.
- Li G, Fu BM. An electrodiffusion model for the blood-brain barrier permeability to charged molecules. J Biomech Eng. 2011;133(2):021002. doi:https://doi.org/10.1115/1.4003309.
- Hervé F, Ghinea N, Scherrmann J-M. CNS delivery via adsorptive transcytosis. AAPS J . 2008;10(3):455–472. doi:https://doi.org/10.1208/s12248-008-9055-2.
- Toth AE, Holst MR, Nielsen MS. Vesicular transport machinery in brain endothelial cells: what we know and what we do not. Curr Pharm Des. 2020;26(13):1405–1416. doi:https://doi.org/10.2174/1381612826666200212113421.
- Kristensen M, Kucharz K, Felipe Alves Fernandes E, Strømgaard K, Schallburg NM, Cederberg HHC, Bach A, Ulrikkaholm Tofte-Hansen M, Irene Aldana Garcia B, Lauritzen M, et al. Conjugation of therapeutic PSD-95 inhibitors to the cell-penetrating peptide Tat affects blood-brain barrier adherence, uptake, and permeation. Pharmaceutics. 2020;12(7):661. doi:https://doi.org/10.3390/pharmaceutics12070661.
- Bocsik A, Walter FR, Gyebrovszki A, Fülöp L, Blasig I, Dabrowski S, Ötvös F, Tóth A, Rákhely G, Veszelka S, et al. Reversible opening of intercellular junctions of intestinal epithelial and brain endothelial cells with tight junction modulator peptides. J Pharm Sci. 2016;105(2):754–765. doi:https://doi.org/10.1016/j.xphs.2015.11.018.
- Bocsik A, Gróf I, Kiss L, Ötvös F, Zsíros O, Daruka L, Fülöp L, Vastag M, Á K, Imre N, et al. Dual action of the PN159/KLAL/MAP peptide: increase of drug penetration across Caco-2 intestinal barrier model by modulation of tight junctions and plasma membrane permeability. Pharmaceutics. 2019;11(2):73. doi:https://doi.org/10.3390/pharmaceutics11020073.
- Westergren I, Johansson BB. Altering the blood-brain barrier in the rat by intracarotid infusion of polycations: a comparison between protamine, poly-L-lysine and poly-L-arginine. Acta Physiol Scand. 1993;149(1):99–104. doi:https://doi.org/10.1111/j.1748-1716.1993.tb09597.x.
- Hart MN, VanDyk LF, Moore SA, Shasby DM, Cancilla PA. Differential opening of the brain endothelial barrier following neutralization of the endothelial luminal anionic charge in vitro. J Neuropathol Exp Neurol. 1987;46(2):141–153. doi:https://doi.org/10.1097/00005072-198703000-00003.
- Ribeiro MMB, Pinto ART, Domingues MM, Serrano I, Heras M, Bardaji ER, Tavares I, Castanho MA. Chemical conjugation of the neuropeptide kyotorphin and ibuprofen enhances brain targeting and analgesia. Mol Pharm. 2011;8(5):1929–1940. doi:https://doi.org/10.1021/mp2003016.
- Santa-Maria AR, Walter FR, Valkai S, Brás AR, Mészáros M, Kincses A, Klepe A, Gaspar D, Castanho MARB, Zimányi L, et al. Lidocaine turns the surface charge of biological membranes more positive and changes the permeability of blood-brain barrier culture models. Biochim Biophys Acta Biomembr. 2019;1861(9):1579–1591. doi:https://doi.org/10.1016/j.bbamem.2019.07.008.
- Born GV, Palinski W. Unusually high concentrations of sialic acids on the surface of vascular endothelia. Br J Exp Pathol. 1985;66:543–549.
- dos Santos WL, Rahman J, Klein N, Male DK. Distribution and analysis of surface charge on brain endothelium in vitro and in situ. Acta Neuropathol. 1995;90(3):305–311. doi:https://doi.org/10.1007/BF00296515.
- Betteridge KB, Arkill KP, Neal CR, Harper SJ, Foster RR, Satchell SC, Bates DO, Salmon AHJ. Sialic acids regulate microvessel permeability, revealed by novel in vivo studies of endothelial glycocalyx structure and function. J Physiol. 2017;595(15):5015–5035. doi:https://doi.org/10.1113/JP274167.
- Kincses A, Santa-Maria AR, Walter FR, Dér L, Horányi N, Lipka DV, Valkai S, Deli MA, Dér A. A chip device to determine surface charge properties of confluent cell monolayers by measuring streaming potential. Lab Chip. 2020;20(20):3792–3805. doi:https://doi.org/10.1039/D0LC00558D.
- Zhu J, Li X, Yin J, Hu Y, Gu Y, Pan S. Glycocalyx degradation leads to blood-brain barrier dysfunction and brain edema after asphyxia cardiac arrest in rats. J Cereb Blood Flow Metab. 2018;38(11):1979–1992. doi:https://doi.org/10.1177/0271678X17726062.
- Broekhuizen LN, Lemkes BA, Mooij HL, Meuwese MC, Verberne H, Holleman F, Schlingemann RO, Nieuwdorp M, Stroes ES, Vink H. Effect of sulodexide on endothelial glycocalyx and vascular permeability in patients with type 2 diabetes mellitus. Diabetologia. 2010;53(12):2646–2655. doi:https://doi.org/10.1007/s00125-010-1910-x.
- Sörensson J, Matejka GL, Ohlson M, Haraldsson B. Human endothelial cells produce orosomucoid, an important component of the capillary barrier. Am J Physiol. 1999;276(2):H530–H534. doi:https://doi.org/10.1152/ajpheart.1999.276.2.H530.
- Yuan W, Li G, Zeng M, Fu BM. Modulation of the blood-brain barrier permeability by plasma glycoprotein orosomucoid. Microvasc Res. 2010;80(1):148–157. doi:https://doi.org/10.1016/j.mvr.2010.03.011.
- Yuan W, Li G, Gil ES, Lowe TL, Fu BM. Effect of surface charge of immortalized mouse cerebral endothelial cell monolayer on transport of charged solutes. Ann Biomed Eng. 2010;38(4):1463–1472. doi:https://doi.org/10.1007/s10439-010-9920-x.
- Zhang S, Mark KS. α1-Acid glycoprotein induced effects in rat brain microvessel endothelial cells. Microvasc Res. 2012;84(2):161–168. doi:https://doi.org/10.1016/j.mvr.2012.05.003.
- Maffrand JP, Herbert JM, Bernat A, Defreyn G, Delebassee D, Savi P, Pinot JJ, Sampol J. Experimental and clinical pharmacology of pentosan polysulfate. Semin Thromb Hemost. 1991;17:186–198.
- Tarbell JM, Cancel LM. The glycocalyx and its significance in human medicine. J Intern Med. 2016;280(1):97–113. doi:https://doi.org/10.1111/joim.12465.
- Kumagai K, Shirabe S, Miyata N, Murata M, Yamauchi A, Kataoka Y, Niwa M. Sodium pentosan polysulfate resulted in cartilage improvement in knee osteoarthritis - An open clinical trial. BMC Clin Pharmacol. 2010;10:7. doi:https://doi.org/10.1186/1472-6904-10-7.
- Dräger LJ, Julius U, Kraenzle K, Schaper J, Toepfer M, Zygan K, Otto V, Steinhagen-Thiessen E. DALI-the first human whole-blood low-density lipoprotein and lipoprotein (a) apheresis system in clinical use: procedure and clinical results. Eur J Clin Invest. 1998;28(12):994–1002. doi:https://doi.org/10.1046/j.1365-2362.1998.00395.x.
- Deli MA, Ábrahám CS, Takahata H, Katamine S, Niwa M. Pentosan polysulfate regulates scavenger receptor-mediated, but not fluid-phase, endocytosis in immortalized cerebral endothelial cells. Cell Mol Neurobiol. 2000;20(6):731–745. doi:https://doi.org/10.1023/a:1007007026500.
- Deli MA, Sakaguchi S, Nakaoke R, Ábrahám CS, Takahata H, Kopáček J, Shigematsu K, Katamine S, Niwa M. PrP fragment 106-126 is toxic to cerebral endothelial cells expressing PrPC. Neuroreport. 2000;11(17):3931–3936. doi:https://doi.org/10.1097/00001756-200011270-00064.
- Veszelka S, Pásztói M, Farkas AE, Krizbai I, Ngo TK, Niwa M, Ábrahám CS, Deli MA. Pentosan polysulfate protects brain endothelial cells against bacterial lipopolysaccharide-induced damages. Neurochem Int. 2007;50(1):219–228. doi:https://doi.org/10.1016/j.neuint.2006.08.006.
- Deli MA, Veszelka S, Csiszár B, Tóth A, Á K, Csete M, Sipos A, Szalai A, Fülöp L, Penke B, et al. Protection of the blood-brain barrier by pentosan against amyloid-β-induced toxicity. J Alzheimers Dis. 2010;22(3):777–794. doi:https://doi.org/10.3233/JAD-2010-100759.
- Fong CW. Statins in therapy: understanding their hydrophilicity, lipophilicity, binding to 3-hydroxy-3-methylglutaryl-CoA reductase, ability to cross the blood brain barrier and metabolic stability based on electrostatic molecular orbital studies. Eur J Med Chem. 2014;85:661–674. doi:https://doi.org/10.1016/j.ejmech.2014.08.037.
- Veszelka S, Tóth A, Walter FR, Tóth AE, Gróf I, Mészáros M, Bocsik A, É H, Vastag M, Rákhely G, et al. Comparison of a rat primary cell-based blood-brain barrier model with epithelial and brain endothelial cell lines: gene expression and drug transport. Front Mol Neurosci. 2018;11:166. doi:https://doi.org/10.3389/fnmol.2018.00166.
- Mehta DC, Short JL, Hilmer SN, Nicolazzo JA. Drug access to the central nervous system in Alzheimer’s disease: preclinical and clinical insights. Pharm Res. 2015;32(3):819–839. doi:https://doi.org/10.1007/s11095-014-1522-0.
- Suzuki T, Moriki Y, Goto H, Tomono K, Hanano M, Watanabe J. Investigation on the influx transport mechanism of pentazocine at the blood-brain barrier in rats using the carotid injection technique. Biol Pharm Bull. 2002;25(10):1351–1355. doi:https://doi.org/10.1248/bpb.25.1351.
- Suzuki T, Ohmuro A, Miyata M, Furuishi T, Hidaka S, Kugawa F, Fukami T, Tomono K. Involvement of an influx transporter in the blood-brain barrier transport of naloxone. Biopharm Drug Dispos. 2010;31(4):243–252. doi:https://doi.org/10.1002/bdd.707.
- Germain M, Caputo F, Metcalfe S, Tosi G, Spring K, Ako Å, Pottier A, Schiffelers R, Ceccaldi A, Schmid R. Delivering the power of nanomedicine to patients today. J Control Release. 2020;326:164–171. doi:https://doi.org/10.1016/j.jconrel.2020.07.007.
- Hua S, Mbc DM, Metselaar JM, Storm G. Current trends and challenges in the clinical translation of nanoparticulate nanomedicines: pathways for translational development and commercialization. Front Pharmacol. 2018;9:790. doi:https://doi.org/10.3389/fphar.2018.00790.
- Sercombe L, Veerati T, Moheimani F, Wu SY, Sood AK, Hua S. Advances and challenges of liposome assisted drug delivery. Front Pharmacol. 2015;6:286. doi:https://doi.org/10.3389/fphar.2015.00286.
- Kevadiya BD, Ottemann BM, Thomas MB, Mukadam I, Nigam S, McMillan J, Gorantla S, Bronich TK, Edagwa B, Gendelman HE. Neurotheranostics as personalized medicines. Adv Drug Deliv Rev. 2019;148:252–289. doi:https://doi.org/10.1016/j.addr.2018.10.011.
- Wechsler ME, Ramirez JEV, Peppas NA. 110th Anniversary: nanoparticle Mediated Drug Delivery for the Treatment of Alzheimer’s Disease: crossing the Blood–Brain Barrier. Ind Eng Chem Res. 2019;58(33):15079–15087. doi:https://doi.org/10.1021/acs.iecr.9b02196.
- Fenart L, Casanova A, Dehouck B, Duhem C, Slupek S, Cecchelli R, Betbeder D. Evaluation of effect of charge and lipid coating on ability of 60-nm nanoparticles to cross an in vitro model of the blood-brain barrier. J Pharmacol Exp Ther. 1999;291:1017–1022.
- Jallouli Y, Paillard A, Chang J, Sevin E, Betbeder D. Influence of surface charge and inner composition of porous nanoparticles to cross blood-brain barrier in vitro. Int J Pharm. 2007;344(1–2):103–109. doi:https://doi.org/10.1016/j.ijpharm.2007.06.023.
- Lockman PR, Koziara JM, Mumper RJ, Allen DD. Nanoparticle surface charges alter blood-brain barrier integrity and permeability. J Drug Target. 2004;12(9–10):635–641. doi:https://doi.org/10.1080/10611860400015936.
- Kristensen K, Engel TB, Stensballe A, Simonsen JB, Andresen TL. The hard protein corona of stealth liposomes is sparse. J Control Release. 2019;307:1–15. doi:https://doi.org/10.1016/j.jconrel.2019.05.042.
- Lombardo SM, Schneider M, Türeli AE, Türeli NG. Key for crossing the BBB with nanoparticles: the rational design. Beilstein J Nanotechnol. 2020;11:866–883. doi:https://doi.org/10.3762/bjnano.11.72.
- MacKay JA, Deen DF, Szoka FC. Distribution in brain of liposomes after convection enhanced delivery; modulation by particle charge, particle diameter, and presence of steric coating. Brain Res. 2005;1035(2):139–153. doi:https://doi.org/10.1016/j.brainres.2004.12.007.
- Campos-Martorell M, Cano-Sarabia M, Simats A, Hernández-Guillamon M, Rosell A, Maspoch D, Montaner J. Charge effect of a liposomal delivery system encapsulating simvastatin to treat experimental ischemic stroke in rats. Int J Nanomedicine. 2016;11:3035–3048. doi:https://doi.org/10.2147/IJN.S107292.
- Gonzalez-Carter D, Goode AE, Kiryushko D, Masuda S, Hu S, Lopes-Rodrigues R, Dexter DT, Shaffer MSP, Porter AE. Quantification of blood-brain barrier transport and neuronal toxicity of unlabelled multiwalled carbon nanotubes as a function of surface charge. Nanoscale. 2019;11(45):22054–22069. doi:https://doi.org/10.1039/c9nr02866h.
- Hanada S, Fujioka K, Inoue Y, Kanaya F, Manome Y, Yamamoto K. Cell-based in vitro blood-brain barrier model can rapidly evaluate nanoparticles’ brain permeability in association with particle size and surface modification. Int J Mol Sci. 2014;15(2):1812–1825. doi:https://doi.org/10.3390/ijms15021812.
- Curtis C, Toghani D, Wong B, Nance E. Colloidal stability as a determinant of nanoparticle behavior in the brain. Colloids Surf B Biointerfaces. 2018;170:673–682. doi:https://doi.org/10.1016/j.colsurfb.2018.06.050.
- Saraiva C, Praça C, Ferreira R, Santos T, Ferreira L, Bernardino L. Nanoparticle-mediated brain drug delivery: overcoming blood-brain barrier to treat neurodegenerative diseases. J Control Release. 2016;235:34–47. doi:https://doi.org/10.1016/j.jconrel.2016.05.044.
- Wohlfart S, Gelperina S, Kreuter J. Transport of drugs across the blood-brain barrier by nanoparticles. J Control Release. 2012;161(2):264–273. doi:https://doi.org/10.1016/j.jconrel.2011.08.017.
- Masserini M. Nanoparticles for brain drug delivery. ISRN Biochem. 2013;2013:238428. doi:https://doi.org/10.1155/2013/238428.
- Kreuter J. Drug delivery to the central nervous system by polymeric nanoparticles: what do we know? Adv Drug Deliv Rev. 2014;71:2–14. doi:https://doi.org/10.1016/j.addr.2013.08.008.
- Gaillard PJ, Appeldoom CCM, Dorland R, Van Kregten J, Manca F, Vugts DJ, Windhorst B, Gams VD, De Vries HE, Maussang D, et al. Pharmacokinetics, brain delivery, and efficacy in brain tumor-bearing mice of glutathione pegylated liposomal doxorubicin (2B3-101). PLoS One. 2014;9(1):e82331. doi:https://doi.org/10.1371/journal.pone.0082331.
- Mészáros M, Porkoláb G, Kiss L, Pilbat A-M, Kóta Z, Kupihár Z, Kéri A, Galbács G, Siklós L, Tóth A, et al. Niosomes decorated with dual ligands targeting brain endothelial transporters increase cargo penetration across the blood-brain barrier. Eur J Pharm Sci. 2018;123:228–240. doi:https://doi.org/10.1016/j.ejps.2018.07.042.
- Porkoláb G, Mészáros M, Tóth A, Szecskó A, Harazin A, Szegletes Z, Ferenc G, Blastyák A, Mátés L, Rákhely G, et al. Combination of alanine and glutathione as targeting ligands of nanoparticles enhances cargo delivery into the cells of the neurovascular unit. Pharmaceutics. 2020;12(7):635. doi:https://doi.org/10.3390/pharmaceutics12070635.
- Woods S, O’Brien LM, Butcher W, Preston JE, Georgian AR, Williamson ED, Salguero FJ, Modino F, Abbott NJ, Roberts CW, et al. Glucosamine-NISV delivers antibody across the blood-brain barrier: optimization for treatment of encephalitic viruses. J Control Release. 2020;324:644–656. doi:https://doi.org/10.1016/j.jconrel.2020.05.048.
- Veszelka S, Mészáros M, Kiss L, Kóta Z, Páli T, Hoyk Z, Bozsó Z, Fülöp L, Tóth A, Rákhely G, et al. Biotin and glutathione targeting of solid nanoparticles to cross human brain endothelial cells. Curr Pharm Des. 2017;23(28):4198–4205. doi:https://doi.org/10.2174/1381612823666170727144450.
- Johnsen KB, Bak M, Melander F, Thomsen MS, Burkhart A, Kempen PJ, Andresen TL, Moos T. Modulating the antibody density changes the uptake and transport at the blood-brain barrier of both transferrin receptor-targeted gold nanoparticles and liposomal cargo. J Control Release. 2019;295:237–249. doi:https://doi.org/10.1016/j.jconrel.2019.01.005.
- Ulbrich K, Hekmatara T, Herbert E, Kreuter J. Transferrin- and transferrin-receptor-antibody-modified nanoparticles enable drug delivery across the blood-brain barrier (BBB). Eur J Pharm Biopharm. 2009;71(2):251–256. doi:https://doi.org/10.1016/j.ejpb.2008.08.021.
- Ulbrich K, Knobloch T, Kreuter J. Targeting the insulin receptor: nanoparticles for drug delivery across the blood-brain barrier (BBB). J Drug Target. 2011;19(2):125–132. doi:https://doi.org/10.3109/10611861003734001.
- Malinovskaya Y, Melnikov P, Baklaushev V, Gabashvili A, Osipova N, Mantrov S, Ermolenko Y, Maksimenko O, Gorshkova M, Balabanyan V, et al. Delivery of doxorubicin-loaded PLGA nanoparticles into U87 human glioblastoma cells. Int J Pharm. 2017;524(1–2):77–90. doi:https://doi.org/10.1016/j.ijpharm.2017.03.049.
- Gupta Y, Jain A, Jain SK. Transferrin-conjugated solid lipid nanoparticles for enhanced delivery of quinine dihydrochloride to the brain. J Pharm Pharmacol. 2007;59(7):935–940. doi:https://doi.org/10.1211/jpp.59.7.0004.
- Kadari A, Pooja D, Gora RH, Gudem S, Kolapalli VRM, Kulhari H, Sistla R. Design of multifunctional peptide collaborated and docetaxel loaded lipid nanoparticles for antiglioma therapy. Eur J Pharm Biopharm. 2018;132:168–179. doi:https://doi.org/10.1016/j.ejpb.2018.09.012.
- Tian X, Wei F, Wang T, Wang P, Lin X, Wang J, Wang D, Ren L. In vitro and in vivo studies on gelatin-siloxane nanoparticles conjugated with SynB peptide to increase drug delivery to the brain. Int J Nanomedicine. 2012;7:1031–1041. doi:https://doi.org/10.2147/IJN.S26541.
- Lu W, Tan Y, Hu K, Jiang X. Cationic albumin conjugated pegylated nanoparticle with its transcytosis ability and little toxicity against blood-brain barrier. Int J Pharm. 2005;295(1–2):247–260. doi:https://doi.org/10.1016/j.ijpharm.2005.01.043.
- Lu W, Zhang Y, Tan YZ, Hu KL, Jiang XG, Fu SK. Cationic albumin-conjugated pegylated nanoparticles as novel drug carrier for brain delivery. J Control Release. 2005;107(3):428–448. doi:https://doi.org/10.1016/j.jconrel.2005.03.027.
- Parikh T, Bommana MM, Squillante E. Efficacy of surface charge in targeting pegylated nanoparticles of sulpiride to the brain. Eur J Pharm Biopharm. 2010;74(3):442–450. doi:https://doi.org/10.1016/j.ejpb.2009.11.001.
- Rao KS, Reddy MK, Horning JL, Labhasetwar V. TAT-conjugated nanoparticles for the CNS delivery of anti-HIV drugs. Biomaterials. 2008;29(33):4429–4438. doi:https://doi.org/10.1016/j.biomaterials.2008.08.004.
- Pinheiro RGR, Granja A, Loureiro JA, Pereira MC, Pinheiro M, Neves AR, Reis S. RVG29-functionalized lipid nanoparticles for quercetin brain delivery and Alzheimer’s disease. Pharm Res. 2020;37(7):139. doi:https://doi.org/10.1007/s11095-020-02865-1.
- Gaillard PJ. BBB crossing assessment and BBB crossing technologies in CNS Drug Discovery. Drug Discov Today Technol. 2016;20:1–3. doi:https://doi.org/10.1016/j.ddtec.2016.11.002.
- Rip J, Chen L, Hartman R, Van Den Heuvel A, Reijerkerk A, Van Kregten J, Van Der Boom B, Appeldoorn C, De Boer M, Maussang D, et al. Glutathione PEGylated liposomes: pharmacokinetics and delivery of cargo across the blood-brain barrier in rats. J Drug Target. 2014;22(5):460–467. doi:https://doi.org/10.3109/1061186X.2014.888070.
- Zlokovic BV, Mackic JB, McComb JG, Weiss MH, Kaplowitz N, Kannan R. Evidence for transcapillary transport of reduced glutathione in vascular perfused guinea-pig brain. Biochem Biophys Res Commun. 1994;201(1):402–408. doi:https://doi.org/10.1006/bbrc.1994.1715.
- Dufes C, Schätzlein AG, Tetley L, Gray AI, Watson DG, Olivier J-C, Couet W, Uchegbu IF. Niosomes and polymeric chitosan based vesicles bearing transferrin and glucose ligands for drug targeting. Pharm Res. 2000;17(10):1250–1258. doi:https://doi.org/10.1023/a:1026422915326.
- Dufes C, Gaillard F, Uchegbu IF, Schätzlein AG, Olivier J-C, Muller J-M. Glucose-targeted niosomes deliver vasoactive intestinal peptide (VIP) to the brain. Int J Pharm. 2004;285(1–2):77–85. doi:https://doi.org/10.1016/j.ijpharm.2004.07.020.
- Gromnicova R, Davies HA, Sreekanthreddy P, Romero IA, Lund T, Roitt IM, Phillips JB, Male DK. Glucose-coated gold nanoparticles transfer across human brain endothelium and enter astrocytes in vitro. PLoS One. 2013;8(12):e81043. doi:https://doi.org/10.1371/journal.pone.0081043.
- Gromnicova R, Kaya M, Romero IA, Williams P, Satchell S, Sharrack B, Male D. Transport of gold nanoparticles by vascular endothelium from different human tissues. PLoS One. 2016;11(8):e0161610. doi:https://doi.org/10.1371/journal.pone.0161610.
- Fatima N, Gromnicova R, Loughlin J, Sharrack B, Male D. Gold nanocarriers for transport of oligonucleotides across brain endothelial cells. PLoS One. 2020;15(9):e0236611. doi:https://doi.org/10.1371/journal.pone.0236611.
- Johnsen KB, Moos T. Revisiting nanoparticle technology for blood-brain barrier transport: unfolding at the endothelial gate improves the fate of transferrin receptor-targeted liposomes. J Control Release. 2016;222:32–46. doi:https://doi.org/10.1016/j.jconrel.2015.11.032.
- van den Berg BM, Nieuwdorp M, Stroes ES, Vink H. Glycocalyx and endothelial (dys) function: from mice to men. Pharmacol Rep. 2006;58:75–80.
- Weinbaum S, Cancel LM, Fu BM, Tarbell JM. The glycocalyx and its role in vascular physiology and vascular related diseases. Cardiovasc Eng Technol. 2021;12(1):37–71. doi:https://doi.org/10.1007/s13239-020-00485-9.
- Yilmaz O, Afsar B, Ortiz A, Kanbay M. The role of endothelial glycocalyx in health and disease. Clin Kidney J. 2019;12(5):611–619. doi:https://doi.org/10.1093/ckj/sfz042.
- Dogné S, Flamion B. Endothelial glycocalyx impairment in disease: focus on hyaluronan shedding. Am J Pathol. 2020;190(4):768–780. doi:https://doi.org/10.1016/j.ajpath.2019.11.016.
- Dogné S, Flamion B, Caron N. Endothelial glycocalyx as a shield against diabetic vascular complications: involvement of hyaluronan and hyaluronidases. Arterioscler Thromb Vasc Biol. 2018;38(7):1427–1439. doi:https://doi.org/10.1161/ATVBAHA.118.310839.
- Logsdon AF, Rhea EM, Reed M, Banks WA, Erickson MA. The neurovascular extracellular matrix in health and disease. Exp Biol Med (Maywood). 2020;10:1535370220977195. doi:https://doi.org/10.1177/1535370220977195.
- Nag S. Cerebral endothelial plasma membrane alterations in acute hypertension. Acta Neuropathol. 1986;70(1):38–43. doi:https://doi.org/10.1007/BF00689512.
- Ueno M, Sakamoto H, Tomimoto H, Akiguchi I, Onodera M, Huang CL, Kanenishi K. Blood-brain barrier is impaired in the hippocampus of young adult spontaneously hypertensive rats. Acta Neuropathol. 2004;107(6):532–538. doi:https://doi.org/10.1007/s00401-004-0845-z.
- Ueno M, Sakamoto H, Liao YJ, Onodera M, Huang CL, Miyanaka H, Nakagawa T. Blood-brain barrier disruption in the hypothalamus of young adult spontaneously hypertensive rats. Histochem Cell Biol. 2004;122(2):131–137. doi:https://doi.org/10.1007/s00418-004-0684-y.
- Gurnik S, Devraj K, Macas J, Yamaji M, Starke J, Scholz A, Sommer K, Di Tacchio M, Vutukuri R, Beck H, et al. Angiopoietin-2-induced blood-brain barrier compromise and increased stroke size are rescued by VE-PTP-dependent restoration of Tie2 signaling. Acta Neuropathol. 2016;131(5):753–773. doi:https://doi.org/10.1007/s00401-016-1551-3.
- Sweeney MD, Ayyadurai S, Zlokovic BV. Pericytes of the neurovascular unit: key functions and signaling pathways. Nat Neurosci. 2016;19(6):771–783. doi:https://doi.org/10.1038/nn.4288.
- Salmon AH, Neal CR, Sage LM, Glass CA, Harper SJ, Bates DO. Angiopoietin-1 alters microvascular permeability coefficients in vivo via modification of endothelial glycocalyx. Cardiovasc Res. 2009;83(1):24–33. doi:https://doi.org/10.1093/cvr/cvp093.
- Ko K, Suzuki T, Ishikawa R, Hattori N, Ito R, Umehara K, Furihata T, Dohmae N, Linhardt RJ, Igarashi K, et al. Ischemic stroke disrupts the endothelial glycocalyx through activation of proHPSE via acrolein exposure. J Biol Chem. 2020;295(52):18614–18624. doi:https://doi.org/10.1074/jbc.RA120.015105.
- Haeren RHL, Rijkers K, Schijns OEMG, Dings J, Hoogland G, Mamj VZ, Vink H, Van Overbeeke JJ In vivo assessment of the human cerebral microcirculation and its glycocalyx: a technical report. J Neurosci Methods. 2018;303:114–125. doi: https://doi.org/10.1016/j.jneumeth.2018.03.009.
- Li X, Zhu J, Liu K, Hu Y, Huang K, Pan S. Heparin ameliorates cerebral edema and improves outcomes following status epilepticus by protecting endothelial glycocalyx in mice. Exp Neurol. 2020;330:113320. doi:https://doi.org/10.1016/j.expneurol.2020.113320.
- Gómez-González B, Larios HM, Escobar A. Increased transvascular transport of WGA-peroxidase after chronic perinatal stress in the hippocampal microvasculature of the rat. Int J Dev Neurosci. 2011;29(8):839–846. doi:https://doi.org/10.1016/j.ijdevneu.2011.08.003.
- Yj L, Ueno M, Nakagawa T, Huang C, Kanenishi K, Onodera M, Sakamoto H. Oxidative damage in cerebral vessels of diabetic db/db mice. Diabetes Metab Res Rev. 2005;21(6):554–559. doi:https://doi.org/10.1002/dmrr.579.
- Neuhaus W, Germann B, Plattner VE, Gabor F, Wirth M, Noe CR. Alteration of the glycocalyx of two blood-brain barrier mimicking cell lines is inducible by glioma conditioned media. Brain Res. 2009;1279:82–89. doi:https://doi.org/10.1016/j.brainres.2009.05.010.
- Rai S, Nejadhamzeeigilani Z, Gutowski NJ, Whatmore JL. Loss of the endothelial glycocalyx is associated with increased E-selectin mediated adhesion of lung tumour cells to the brain microvascular endothelium. J Exp Clin Cancer Res. 2015;34:105. doi:https://doi.org/10.1186/s13046-015-0223-9.
- Behling-Kelly E, Vonderheid H, Kim KS, Corbeil LB, Czuprynski CJ. Roles of cellular activation and sulfated glycans in Haemophilus somnus adherence to bovine brain microvascular endothelial cells. Infect Immun. 2006;74(9):5311–5318. doi:https://doi.org/10.1128/IAI.00614-06.
- Okada H, Yoshida S, Hara A, Ogura S, Tomita H, Vascular endothelial injury exacerbates coronavirus disease 2019: the role of endothelial glycocalyx protection. Microcirculation. 2020;e12654. in press. doi:https://doi.org/10.1111/micc.12654.
- Pillinger NL, Kam P. Endothelial glycocalyx: basic science and clinical implications. Anaesth Intensive Care. 2017;45(3):295–307. doi:https://doi.org/10.1177/0310057X1704500305.
- Goligorsky MS, Sun D. Glycocalyx in endotoxemia and sepsis. Am J Pathol. 2020;190(4):791–798. doi:https://doi.org/10.1016/j.ajpath.2019.06.017.
- Nägga K, Hansson O, Van Westen D, Minthon L, Wennström M. Increased levels of hyaluronic acid in cerebrospinal fluid in patients with vascular dementia. J Alzheimers Dis. 2014;42(4):1435–1441. doi:https://doi.org/10.3233/JAD-141200.
- DellaValle B, Manresa-Arraut A, Hasseldam H, Stensballe A, Rungby J, Larsen A, Hempel C. Detection of glycan shedding in the blood: new class of multiple sclerosis biomarkers? Front Immunol. 2018;9:1254. doi:https://doi.org/10.3389/fimmu.2018.01254.
- Piva S, McCreadie VA, Latronico N. Neuroinflammation in sepsis: sepsis associated delirium. Cardiovasc Hematol Disord Drug Targets. 2015;15(1):10–18. doi:https://doi.org/10.2174/1871529x15666150108112452.
- Hippensteel JA, Anderson BJ, Orfila JE, McMurtry SA, Dietz RM, Su G, Ford JA, Oshima K, Yang Y, Zhang F, et al. Circulating heparan sulfate fragments mediate septic cognitive dysfunction. J Clin Invest. 2019;129(4):1779–1784. doi:https://doi.org/10.1172/JCI124485.
- Zhang X, Han X, Xia K, Xu Y, Yang Y, Oshima K, Haeger SM, Perez MJ, McMurtry SA, Hippensteel JA, et al. Circulating heparin oligosaccharides rapidly target the hippocampus in sepsis, potentially impacting cognitive functions. Proc Natl Acad Sci U S A. 2019;116(19):9208–9213. doi:https://doi.org/10.1073/pnas.1902227116.
- Torres Filho IP, Torres LN, Salgado C, Dubick MA. Plasma syndecan-1 and heparan sulfate correlate with microvascular glycocalyx degradation in hemorrhaged rats after different resuscitation fluids. Am J Physiol Heart Circ Physiol. 2016;310(11):H1468–H1478. doi:https://doi.org/10.1152/ajpheart.00006.2016.
- Dobson GP. Trauma of major surgery: a global problem that is not going away. Int J Surg. 2020;81:47–54. doi:https://doi.org/10.1016/j.ijsu.2020.07.017.
- Song JW, Zullo JA, Liveris D, Dragovich M, Zhang XF, Goligorsky MS. Therapeutic restoration of endothelial glycocalyx in sepsis. J Pharmacol Exp Ther. 2017;361(1):115–121. doi:https://doi.org/10.1124/jpet.116.239509.
- Torres Filho IP, Torres LN, Salgado C, Dubick MA. Novel adjunct drugs reverse endothelial glycocalyx damage after hemorrhagic shock in rats. Shock. 2017;48(5):583–589. doi:https://doi.org/10.1097/SHK.0000000000000895.
- Torres LN, Chung KK, Salgado CL, Dubick MA, Torres Filho IP. Low-volume resuscitation with normal saline is associated with microvascular endothelial dysfunction after hemorrhage in rats, compared to colloids and balanced crystalloids. Crit Care. 2017;21(1):160. doi:https://doi.org/10.1186/s13054-017-1745-7.
- Haywood-Watson RJ, Holcomb JB, Gonzalez EA, Peng Z, Pati S, Park PW, Wang W, Zaske AM, Menge T, Kozar RA. Modulation of syndecan-1 shedding after hemorrhagic shock and resuscitation. PLoS One. 2011;6(8):e23530. doi:https://doi.org/10.1371/journal.pone.0023530.
- Genét GF, Bentzer P, Ostrowski SR, Johansson PI. Resuscitation with pooled and pathogen-reduced plasma attenuates the increase in brain water content following traumatic brain injury and hemorrhagic shock in rats. J Neurotrauma. 2017;34(5):1054–1062. doi:https://doi.org/10.1089/neu.2016.4574.
- Tuma M, Canestrini S, Alwahab Z, Marshall J. Trauma and endothelial glycocalyx: the microcirculation helmet? Shock (Augusta, Ga.). 2016;46(4):352–357. doi:https://doi.org/10.1097/SHK.0000000000000635.
- Gerhartl A, Hahn K, Neuhoff A, Friedl HP, Förster CY, Wunder C, Schick M, Burek M, Neuhaus W. Hydroxyethylstarch (130/0.4) tightens the blood-brain barrier in vitro. Brain Res. 2020;1727:146560. doi:https://doi.org/10.1016/j.brainres.2019.146560.
- Hempel C, Sporring J, Kurtzhals JAL. Experimental cerebral malaria is associated with profound loss of both glycan and protein components of the endothelial glycocalyx. Faseb J. 2019;33(2):2058–2071. doi:https://doi.org/10.1096/fj.201800657R.
- McLaughlin S. Electrostatic potentials at membrane-solution interfaces. Curr Top Membr Transp. 1977;9:71–144. doi:https://doi.org/10.1016/S0070-2161(08)60677-2.
- Butt HJ. Measuring local surface charge densities in electrolyte solutions with a scanning force microscope. Biophys J. 1992;63(2):578–582. doi:https://doi.org/10.1016/S0006-3495(92)81601-6.
- Sotres J, Baró AM. AFM imaging and analysis of electrostatic double layer forces on single DNA molecules. Biophys J. 2010;98(9):1995–2004. doi:https://doi.org/10.1016/j.bpj.2009.12.4330.
- Perry D, Paulose Nadappuram B, Momotenko D, Voyias PD, Page A, Tripathi G, Frenguelli BG, Unwin PR. Surface charge visualization at viable living cells. J Am Chem Soc. 2016;138(9):3152–3160. doi:https://doi.org/10.1021/jacs.5b13153.
- Malher E, Martin D, Duvivier C, Volochine B, Stoltz JF. New device for determination of cell electrophoretic mobility using doppler velocimetry. Biorheology. 1982;19(5):647–654. doi:https://doi.org/10.3233/bir-1982-19506.
- Santa-Maria AR, Walter FR, Figueiredo R, Kincses A, Vigh JP, Heymans M, Culot M, Winter P, Gosselet F, Dér A, et al. Flow induces barrier and glycocalyx-related genes and negative surface charge in a lab-on-a-chip human blood-brain barrier model. J Cereb Blood Flow Metab. 2021;271678X21992638. in press doi:https://doi.org/10.1177/0271678X21992638.
- Fike RM, Van Oss CJ. Zeta-potentials of intact cell monolayers determined by electro-osmosis. In Vitro. 1976;12(6):428–436. doi:https://doi.org/10.1007/BF02806022.
- Sawyer PN, Himmelfarb E, Lustrin I, Ziskind H. Measurement of streaming potentials of mammalian blood vessels, aorta and vena cava, in vivo. Biophys J. 1966;6(5):641–651. doi:https://doi.org/10.1016/S0006-3495(66)86683-3.
- Walter FR, Valkai S, Kincses A, Petneházi A, Czeller T, Veszelka S, Ormos P, Deli MA, Dér A. A versatile lab-on-a-chip tool for modeling biological barriers. Sens Actuators B Chem. 2016;222:1209–1219. doi:https://doi.org/10.1016/j.snb.2015.07.110.
- Szabó CA, Deli MA, Dung NTK, Joó F. Production of pure primary rat cerebral endothelial cell culture: a comparison of different methods. Neurobiology (Budapest). 1997;5:1–16.
- Forsberg KME, Zhang Y, Reiners J, Ander M, Niedermayer A, Fang L, Neugebauer H, Kassubek J, Katona I, Weis J, et al. Endothelial damage, vascular bagging and remodeling of the microvascular bed in human microangiopathy with deep white matter lesions. Acta Neuropathol Commun. 2018;6(1):128. doi:https://doi.org/10.1186/s40478-018-0632-z.
- Nag S. Ultrastructural localization of monosaccharide residues on cerebral endothelium. Lab Invest. 1985;52(5):553–558. doi:https://doi.org/10.1007/BF00688684.
- Nishida S, Akai F, Hiruma S, Maeda M, Tanji K, Hashimoto S. Experimental study of WGA binding on the endothelial cell surface in cerebral ischemia. Histol Histopathol. 1986;1(1):69–74
- Mazzetti S, Librizzi L, Frigerio S, De Curtis M, Vitellaro-Zuccarello L. Molecular anatomy of the cerebral microvessels in the isolated guinea-pig brain. Brain Res. 2004;999(1):81–90. doi:https://doi.org/10.1016/j.brainres.2003.11.032.
- Fischer D, Kissel T. Histochemical characterization of primary capillary endothelial cells from porcine brains using monoclonal antibodies and fluorescein isothiocyanate-labelled lectins: implications for drug delivery. Eur J Pharm Biopharm. 2001;52(1):1–11. doi:https://doi.org/10.1016/s0939-6411(01)00159-x.
- Fatehi MI, Gerhart DZ, Myers TG, Drewes LR. Characterization of the blood-brain barrier: glycoconjugate receptors of 14 lectins in canine brain, cultured endothelial cells, and blotted membrane proteins. Brain Res. 1987;415(1):30–39. doi:https://doi.org/10.1016/0006-8993(87)90266-6.
- Nieuwdorp M, Meuwese MC, Mooij HL, Ince C, Broekhuizen LN, Kastelein JJ, Stroes ES, Vink H. Measuring endothelial glycocalyx dimensions in humans: a potential novel tool to monitor vascular vulnerability. J Appl Physiol. 2008;104(3):845–852. doi:https://doi.org/10.1152/japplphysiol.00440.2007.
- Yoon J-H, Lee E-S, Jeong Y. In vivo imaging of the cerebral endothelial glycocalyx in mice. J Vasc Res. 2017;54(2):59–67. doi:https://doi.org/10.1159/000457799.
- Nag S. Cerebral endothelial surface charge in hypertension. Acta Neuropathol. 1984;63(4):276–281. doi:https://doi.org/10.1007/BF00687333.
- Ueno M, Tomita S, Nakagawa T, Ueki M, Iwanaga Y, Ono J, Onodera M, Huang CL, Kanenishi K, Shimada A, et al. Effects of aging and HIF-1alpha deficiency on permeability of hippocampal vessels. Microsc Res Tech. 2006;69(1):29–35. doi:https://doi.org/10.1002/jemt.20266.
- Vorbrodt AW, Trowbridge RS. Aluminum-induced alteration of surface anionic sites in cultured brain microvascular endothelial cells. Acta Neuropathol. 1993;86(4):371–377. doi:https://doi.org/10.1007/BF00369450.
- Hempel C, Hyttel P, Kurtzhals JA. Endothelial glycocalyx on brain endothelial cells is lost in experimental cerebral malaria. J Cereb Blood Flow Metab. 2014;34(7):1107–1110. doi:https://doi.org/10.1038/jcbfm.2014.79.
- Haeren RHL, Sem VDV, Mamj VZ, Vink H, Van Overbeeke JJ, Hoogland G, Rijkers K. Assessment and imaging of the cerebrovascular glycocalyx. Curr Neurovasc Res. 2016;13(3):249–260. doi:https://doi.org/10.2174/1567202613666160504104434.
- Haeren RHL, Vink H, Staals J, Mamj VZ, Dings J, Van Overbeeke JJ, Hoogland G, Rijkers K, Schijns OEMG. Protocol for intraoperative assessment of the human cerebrovascular glycocalyx. BMJ Open. 2017;7(1):e013954. doi:https://doi.org/10.1136/bmjopen-2016-013954.